AD/PD 2023

28 Mar - 1 Apr, 2023

The AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders was held in Gothenberg, Sweden, spotlighting exciting news from another fantastic year of basic and clinical research in the neurodegenerative disease space. Speaking to expert presenters from across the globe, VJDementia are delighted to bring you exclusive insights straight from the meeting!

Explore below!

View all videos

Browse Popular Uploads...

European task force recommendations: shifting memory clinics towards prevention

Giovanni Frisoni • 30 Mar 2023

Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease

Suzanne Hendrix • 21 Mar 2023

TRAILBLAZER-ALZ 4: direct comparison of donanemab and aducanumab

Stephen Salloway • 19 Apr 2023

How does TPS work in Alzheimer’s disease?

Lars Wojtecki • 23 Mar 2023

Biomarker Breakthroughs

Streamlining dementia diagnosis with digital biomarkers

M. Florencia Iulita • 28 Mar 2023

CSF synaptic markers in Alzheimer’s disease

Andrea Pilotto • 23 Mar 2023

Decreased kidney function associated with increased plasma p-tau levels

Bruna Bellaver • 24 Mar 2023

Detecting retinal Aβ: a promising path for non-invasive Alzheimer’s disease diagnosis

Mourad Tayebi • 30 Mar 2023

Novel Treatment Updates

Phase II trial of AR1001 as a potential treatment for Alzheimer’s disease

David Greeley • 28 Mar 2023

Safety results of the Phase III gantenerumab GRADUATE I and II studies

Stephen Salloway • 19 Apr 2023

Improving the next generation of anti-amyloid antibodies: prioritizing selectivity with PMN310

Johanne Kaplan • 30 Mar 2023

All-in-one AAV vector for epigenome editing shows efficient APOE downregulation in vivo

Boris Kantor • 15 Mar 2023